A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA

  1. Markus Bitzer1,6,
  2. Gero von Gersdorff1,6,
  3. Dan Liang1,
  4. Alfredo Dominguez-Rosales4,
  5. Amer A. Beg5,
  6. Marcos Rojkind1,3,4, and
  7. Erwin P. Böttinger1,2,7
  1. 1Departments of Medicine, 2Molecular Genetics and 3Pathology, and 4Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461 USA; 5Department of Biological Sciences, Columbia University, New York, New York 10027 USA

Abstract

A number of pathogenic and proinflammatory stimuli, and the transforming growth factor-β (TGF-β) exert opposing activities in cellular and immune responses. Here we show that the RelA subunit of nuclear factor κB (NF-κB/RelA) is necessary for the inhibition of TGF-β-induced phosphorylation, nuclear translocation, and DNA binding of SMAD signaling complexes by tumor necrosis factor-α (TNF-α). The antagonism is mediated through up-regulation of Smad7 synthesis and induction of stable associations between ligand-activated TGF-β receptors and inhibitory Smad7. Down-regulation of endogenous Smad7 by expression of antisense mRNA releases TGF-β/SMAD-induced transcriptional responses from suppression by cytokine-activated NF-κB/RelA. Following stimulation with bacterial lipopolysaccharide (LPS), or the proinflammatory cytokines TNF-α and interleukin-1β (IL-1β, NF-κB/RelA induces Smad7 synthesis through activation of Smad7 gene transcription. These results suggest a mechanism of suppression of TGF-β/SMAD signaling by opposing stimuli mediated through the activation of inhibitory Smad7 by NF-κB/RelA.

Keywords

Footnotes

  • 6 These two authors contributed equally to this work.

  • 7 Corresponding author.

  • E-MAIL bottinge{at}aecom.yu.edu; FAX (718) 430-8963.

    • Received October 20, 1999.
    • Accepted December 1, 1999.
| Table of Contents

Life Science Alliance